溶解性を高めるため,イバカフターを含む固体脂質ナノ粒子の最適化
Akshay Parihar1,2, Bhupendra G Prajapati3,4,5, Himanshu Paliwal6
1Faculty of Pharmacy, Ganpat University, Mehsana, Gujarat, India.
Frontiers in pharmacology
|September 5, 2025
まとめ
この研究では,イヴァカフトール (IVF) 用の最適化された固体脂質ナノ粒子 (SLN) が, cystic fibrosis (CF) の治療に開発されました. 薬剤の放出が改善され,CFの治療効果が向上する可能性があることが示されました.
科学分野:
- ナノテクノロジー
- 医薬品科学
- 薬物投与システム
背景:
- 胞性線維症 (Cystic Fibrosis,CF) は多臓器性全身性疾患で,著しい罹病率と死亡率を有する.
- 肺の合併症は主であり,関連疾患は他の臓器に影響します.
- 効果的な治療戦略は 決定的に重要です
研究 の 目的:
- イバカフター (IVF) 投与のための固体脂質ナノ粒子 (SLN) の開発と最適化.
- イバカフトールの治療効果を高めるために
- 脂質と表面活性物質の濃度が配方特性に与える影響を調査する.
主な方法:
- イバカフターを含む固体脂質ナノ粒子 (IVF-SLN) は,均質化と超音波処理を用いて製造された.
- ラブラゾール (液体脂質),セチルパルミテート (固体脂質),ポリソルベート20 (表面活性剤) が使用された.
- 最適化には,脂質と表面活性物質の量を捕まえる効率と粒子の大きさについて研究することが含まれていた.
主要な成果:
- 最適化されたIVF-SLN製剤は,粒子の大きさが150.23 ± 1.59nm,捕獲効率が90.54 ± 1.32%に達した.
- ディフェンショナル・スキャニング・カロミテリー (DSC) によって,イヴァカフトールの脂質マトリックスへの組み込みが確認されました.
- In vitro溶解試験では,第1次運動に続く持続的な放出プロファイルが示されました.
結論:
- イバカフター (IVF) のための安定した固体脂質ナノ粒子 (SLN) が成功裏に開発されました.
- この薬剤は持続的な薬剤放出パターンを示し,フリー薬よりも治療の可能性が向上したことを示唆した.
- このナノ粒子システムは 胞性線維症の管理に 有望な戦略を示しています
関連する概念動画
Factors Affecting Dissolution: Particle Size and Effective Surface Area
1.0K
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
1.0K
Factors Affecting Dissolution: Drug pKa, Lipophilicity and GI pH
1.9K
Drug absorption within the gastrointestinal (GI) tract is a complex process influenced by several critical factors, including the site pH, the drug's dissociation constant (pKa), and the drug's lipophilicity. The GI tract exhibits a pH gradient, with an acidic environment in the stomach and a more alkaline environment in the small intestine. This pH variation directly affects the ionization state of drugs.
A drug's pKa and the pH of the gastrointestinal (GI) tract play crucial roles...
A drug's pKa and the pH of the gastrointestinal (GI) tract play crucial roles...
1.9K
Factors Influencing Drug Absorption: Drug Dissolution
690
The pharmacokinetic journey of drugs from solid oral dosage forms into systemic circulation is multifaceted. It begins with disintegration, a prerequisite ensuring a solid dosage form's subdivision into minute particles. Dissolution occurs next as these granulated entities solubilize in gastrointestinal fluids. This solubilization is crucial for the succeeding stage, permeation, which describes the traversal of the drug across the intestinal membrane and its subsequent entry into the blood...
690
Factors Affecting Solubility
33.9K
Compared with pure water, the solubility of an ionic compound is less in aqueous solutions containing a common ion (one also produced by dissolution of the ionic compound). This is an example of a phenomenon known as the common ion effect, which is a consequence of the law of mass action that may be explained using Le Chȃtelier’s principle. Consider the dissolution of silver iodide:
33.9K
Factors Influencing Drug Absorption: Physicochemical Parameters
425
The physicochemical characteristics of drugs play a crucial role in formulating stable and bioavailable drug products. The solubility of a drug, governed by the varying pH along the GI tract and its dissociation constant (pKa), is pivotal in determining its ionization state and absorption rate. Notably, weak acids and bases remain unionized and are absorbed more rapidly.
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
425
One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution
491
The one-compartment open model is a simplified approach used in pharmacokinetics to understand the distribution and elimination of a drug administered through an intravenous bolus. This model assumes rapid drug dispersal throughout the body and elimination using a first-order process. Key pharmacokinetic parameters, such as the elimination rate constant (k), half-life (t1/2), and the apparent volume of distribution (Vd), can be estimated from this model. The elimination rate is calculated...
491


